FUJIWARA, Y., YOSHIKAWA, R., KAMIKONYA, N., NAKAYAMA, T., KITANI, K., TSUJIE, M., . . . YAMAMURA, T. (2012). Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients. D.A. Spandidos.
Citação norma ChicagoFUJIWARA, YOSHINORI, REIGETSU YOSHIKAWA, NORIHIKO KAMIKONYA, TSUYOSHI NAKAYAMA, KOTARO KITANI, MASANORI TSUJIE, MASAO YUKAWA, MASATOSHI INOUE, and TAKEHIRA YAMAMURA. Trimodality Therapy of Esophagectomy Plus Neoadjuvant Chemoradiotherapy Improves the Survival of Clinical Stage II/III Esophageal Squamous Cell Carcinoma Patients. D.A. Spandidos, 2012.
Citação norma MLAFUJIWARA, YOSHINORI, et al. Trimodality Therapy of Esophagectomy Plus Neoadjuvant Chemoradiotherapy Improves the Survival of Clinical Stage II/III Esophageal Squamous Cell Carcinoma Patients. D.A. Spandidos, 2012.